Refractory thyroid cancer: A paradigm shift in treatment is not far off Journal Article

  

Authors:	Pfister, D. G.; Fagin, J. A.
Article Title:	Refractory thyroid cancer: A paradigm shift in treatment is not far off
Keywords:	cancer survival; gene mutation; clinical trial; sorafenib; cisplatin; doxorubicin; cancer combination chemotherapy; unspecified side effect; paclitaxel; cancer patient; carboplatin; melanoma; editorial; drug mechanism; bleomycin; thyroid cancer; thyroid neoplasms; axitinib; somatostatin derivative
Journal Title:	Journal of Clinical Oncology
Volume:	26
Issue:	29
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2008-10-10
Start Page:	4701
End Page:	4704
Language:	English
DOI:	10.1200/jco.2008.17.3682
PUBMED:	18541893
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-50649101341&partnerID=40&md5=e7d508b1808619849970dcb5792823c4
Notes:	--- - "Cited By (since 1996): 20" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/15135